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Abstract
Head and neck cancer (HNC) currently affects approximately 11 200 people in the UK, with an increasing proportion known to be caused by the human
papillomavirus (HPV). We undertook a systematic review of studies measuring the psychosocial impact of HPV-related HNC and also studies measuring
knowledge about the link between HPV and HNC among different populations. Searches were conducted on MEDLINE, Embase, PsycINFO, CINAHL Plus and Web
of Science, with reference and forward citation searches also carried out on included studies. Studies were selected if they (i) were original peer-reviewed
research (qualitative or quantitative), (ii) mentioned HPV and HNC, (iii) measured an aspect of the psychosocial impact of the diagnosis of HPV-related HNC
as the dependent variable and/or (iv) measured knowledge of the association between HPV and HNC. In total, 51 papers met the inclusion criteria; 10 measuring
psychosocial aspects and 41 measuring knowledge of the link between HPV and HNC. Quality of life in those with HPV-positive HNC was found to be higher,
lower or equivalent to those with HPV-negative HNC. Longitudinal studies found quality of life in patients was at its lowest 2e3 months after diagnosis and
some studies found quality of life almost returned to baseline levels after 12 months. Knowledge of the link between HPV and HNC was measured among
different populations, with the lowest knowledge in the general population and highest in medical and dental professionals. Due to the limited studies carried
out with patients measuring the psychosocial impact of a diagnosis of HPV-positive HNC, future work is needed with the partners of HPV-positive HNC patients
and health professionals caring for these patients. The limited knowledge of the association between HPV and HNC among the general population also indicates
the need for research to explore the information that these populations are receiving.
 2016 The Royal College of Radiologists. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).
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Head and neck cancer (HNC) affects about 11 200 people
in the UK each year [1e4] and there are currently 62 500
survivors of the disease [5]. Diagnosis is associated with
well-recognised psychosocial sequelae, including difﬁ-
culties with communication with the partner, functioning
in the family, and social and interpersonal relationships [6].
Patients have also been found to isolate themselves from
their friends and family due to the disﬁguring impact of
treatment on their appearance [7], and many feel stigma-
tised [8]. Practical issues, such as problems with speaking,
can also interfere with communication, and poorer
communication has been found to result in greater distress
[9]. Negative psychological consequences tend to be worse
for patients undergoing surgery than those receiving
alternative methods of treatment [10e12].is is an open access article under the CC BY license (http://creativecommons.
R.H. Dodd et al. / Clinical Oncology 28 (2016) 421e439422It is now clear that an increasing proportion of HNC cases
are caused by the human papillomavirus (HPV) [13e16],
which has long been associated with cervical and other
anogenital cancers [17]. The incidence of HPV-related HNC is
rising [18], with numbers in the USA set to surpass the
numbers of cervical cancer cases by 2020 if the current trend
continues [19]. Patients with HPV-positive HNC are typically
younger than those with HPV-negative disease, and tend to
be white, male, married, educated and employed [20]. Risk
factors are thought to be a greater lifetime number of sexual
andoral sexpartners [20e23] due togreaterexposure toHPV.
We know from the cervical cancer literature that the
sexually transmitted nature of HPV can lead to additional
psychological challenges to those associated with the cancer
itself. Women have felt stigma, anxiety, concern about their
relationships and worry about disclosure of their test results
to others, following a diagnosis of HPV in the context of cer-
vical screening [24]. As the link between HPV and HNC has
been established, there has been increasing recognition of
the need for guidance on how to discuss HPV with patients
[25e27]. Behavioural and psychological science has made a
signiﬁcant contribution to understanding and addressing
psychosocial issues associated with both HNC and HPV. One
study measuring the supportive care needs of HNC patients
found overwhelming evidence of unmet psychological needs
[28] and a Cochrane review paper found a number of rand-
omised controlled trials implementing psychosocial in-
terventions for HNC patients, but concluded there was not
enough evidence to conclude on their effectiveness [29]. It is
also important to assess knowledge of the association be-
tweenHPV andHNC among different populations, to identify
gaps in knowledge and inform communication strategies.
Research has started to explore what the public know
about HPV and HNC and how an HPV diagnosis affects pa-
tients. Knowledge of HPV appears to have increased
following the introduction of the HPV vaccination, which is
now offered to adolescents in most developed countries
[30]. In the context of cervical cancer, an online survey of
adults in the UK, USA and Australia following the intro-
duction of the HPV vaccination showed 61% reported having
heard of HPV [31]. By contrast, public awareness of the signs
and risk factors for HNC has been shown to be poor [32]. In
the clinical context, few resources currently exist to answer
patients’ concerns about how, when and why they got their
cancer [27], the answers to which can have implications
both for the patient and their past, present or future
partners.
This review is timely in drawing together ﬁndings from
the emerging literature and identifying priorities for a
behavioural science research agenda in this ﬁeld. The evi-
dence from both the cervical cancer and HNC literature
suggests that there may be greater psychological distress in
these patients due to the combination of both a diagnosis of
cancer and of HPV. The review aims to answer two
questions:
(i) What is the psychological impact of an HPV diagnosis in
the context of HNC?(ii) What is known about HPV-related HNC in different
population groups?Materials and Methods
Search Methods for Identiﬁcation of Studies
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines were followed for this
systematic review [33]. Search terms were developed in
consultation with a librarian at UCL and through extracting
key terms from previous review papers and relevant pri-
mary research. Terms covered (i) the health condition of
interest (e.g. HPV, human papillomavirus, head and neck
cancer), (ii) psychosocial outcomes of interest (e.g. psy-
chosocial, depression, anxiety, quality of life) and (iii)
knowledge (e.g. knowledge, awareness). The full search
strategies for each database can be found in the
Supplementary Material. Initial search terms were later
reﬁned based on common text words from relevant articles
retrieved from the search. MEDLINE, Embase and PsycINFO
databases were accessed through Ovid databases and were
searched from inception to present in December 2014.
Search terms were adapted for CINAHL Plus and Web of
Science. These databases were chosen based on previous
review papers in this ﬁeld and because all databases will
complement each other and allow a broader scope of
coverage. There were no language or date restrictions
applied to the search. The reference lists of included studies
were searched (RD) for additional relevant papers. The grey
literature was also searched using OPENSIGLE (opensigle.
inist.fr). Results of the literature search were downloaded
into Endnote with duplicate articles removed.
Inclusion and Exclusion Criteria
Studies were included if they (i) were original peer-
reviewed research (qualitative or quantitative), (ii)
mentioned HPV and HNC, (iii) measured an aspect of the
psychosocial impact of the diagnosis of HPV-related HNC as
the dependent variable and/or (iv) measured knowledge of
the association between HPV and HNC. Studies were
excluded if they were not written in English, did not report
original research or were conference abstracts.
Selection Procedure and Quality Assessment
Article titles were screened by two authors (RD, JW) and
were excluded if they were not written in the English
language or were clearly irrelevant to the review. Two
members of the review team (RD, LM) then screened the
abstracts of the remaining articles, looking more specif-
ically for articles mentioning HPV. Authors of conference
abstracts that appeared to meet the eligibility criteria were
contacted to request a copy of the full paper if it was
available. Those not submitted or published in peer-review
R.H. Dodd et al. / Clinical Oncology 28 (2016) 421e439 423journals were excluded and one author did not reply after
multiple attempts to contact them, so this paper was also
excluded. Disagreements were resolved by discussion and
reasons for inclusion/exclusion were noted. Articles that
appeared to meet the inclusion criteria based on the titleS
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R.H. Dodd et al. / Clinical Oncology 28 (2016) 421e439424A full-text eligibility review was conducted by two
members of the review team (RD, LM) with reasons for
exclusion recorded. Reasons for excluding studies included
the article not containing any original data relevant to our
eligibility criteria, not mentioning HPV or not measuring
our outcomes of interest as dependent variables. Forward
citation searches were conducted for all papers obtained for
full-text review and included those published up to August
2015. Eligibility of articles found through forward citation
and reference searching was conﬁrmed by a second
screener (LM). A summary of the data from all full-text ar-
ticles was extracted (Tables 1, 2) into Microsoft Excel and
the quality of the studies was assessed using an amended
version of the National Institute for Health and Care
Excellence (NICE) quality appraisal checklists for quantita-
tive and qualitative studies [34]. This considered a range of
factors, which included whether the source population was
well described, whether the outcome measures were reli-
able and relevant, whether the analytical methods were
appropriate and whether the ﬁndings could be generalised
to the source population.
Analysis
Data from all included articles were recorded using a
data extraction form. The results from articles measuring
psychosocial outcomes and knowledge are reported
descriptively with comparisons drawn where appropriate.
Qualitative ﬁndings are described separately.Results
Search Results
The initial search returned 782 articles, which was
reduced to 491 after the removal of duplicates; 448 were
excluded on the basis of their title, leaving 43 abstracts to be
reviewed. Once the articles had been screened by title and
abstract, 25 were obtained for full-text review. An addi-
tional 37 articles were included after searching the refer-
ence lists, relevant review papers found through the search
and searching forward citations of those already obtained
for full-text review. Eleven articles were excluded during
full-text review, leaving 51 papers included in the ﬁnal
analysis. Figure 1 shows the study selection process. All the
authors agreed on the ﬁnal papers included in the review.
Studies Assessing the Psychosocial Impact of Human
Papillomavirus-related Head and Neck Cancer
Ten of the studies measured psychosocial outcomes
[35e44]. Of these, eight were conducted in the USA
[35,37e40,42e44], one was conducted in Switzerland [36]
and one in Italy [41]. Quantitative studies used survey-
based methods [36e38,40e44] and conducted an audit on
medical records [39]. One article collected qualitative data
from individual interviews [35]. All articles were published
between 2012 and 2014. In some studies, p16 expressionwas used as a marker of HPV status, but for simplicity we
refer to patients as HPV-positive throughout the review.
The psychosocial impact of HPV-related HNC was
measured inpatients [35e44] at different timepoints in their
care continuum from newly diagnosed [36,38,40,42,43], to
up to 5 years post treatment completion [35].
Quality of Life Measures
Quality of life was the main outcome measure used in
seven studies andwasmeasured using a number of different
tools. Six of the studiesmeasuring quality of life used at least
one HNC-speciﬁc measure (Table 3). Two studies used the
Head and Neck Cancer Inventory (HNCI) [37,38], which is a
validated 30-item survey measuring patient-reported
quality of life status in speech, eating, aesthetics and social
disruption. Three studies used the University ofWashington
Quality of Life (UWQOL) measure [40,43,44], which is a
validated HNC-speciﬁc quality of life questionnaire
including 12 domains, with two subscales of physical and
social-emotional functioning. One study used the European
Organization for Research and Treatment of Cancer (EORTC)
HNC-speciﬁc version (QLQ-H&N35) [36], which includes
seven scales measuring pain, swallowing, senses, speech,
social eating, social contact and sexuality. One study used
HeadandNeckQuality of Life (HNQOL) [44],whichmeasures
the four domains of eating, communication, pain and
emotion. Generic measures were also used in three studies
and included theMedical Outcome Study Short Form36 (SF-
36) [44], which is a 36-itemgenericmeasure of health status
split into 10 domains, the EQ-5D [41], which has ﬁve di-
mensions ofmeasuring quality of life, and the EORTC general
core questionnaire (QLQ-C30) [36] measuring activity,
physical and social functioning. Other psychosocial mea-
sures used were the National Comprehensive Cancer Net-
work’s distress thermometer, which uses a scale from0 to 10
for patients to indicate how much distress they have been
experiencing in the last week, and the Glinder and Compas
one-itemmeasure of behavioural blame [42] (i.e. ‘Howmuch
do you blame yourself for the kinds of things you did, that is,
for any behaviours that may have led to your cancer?’).
Studies with Human Papillomavirus-positive Patients Only
Three studies did not include a comparison between
HPV-positive patients and HPV-negative patients
[35,42,44]. The one qualitative study with HPV-positive
HNC survivors reported that 3/10 cancer survivors felt a
sense of stigma or shame associated with their diagnosis
[35]. The second study measured distress and self-blame in
newly diagnosed HPV-positive patients [42]. Distress levels
were found to be moderate (mean 3.38, range 0e9), with
30% showing clinically meaningful scores (scores above or
equal to 4). Self-blame levels were found to be low (mean
2.27, range 1e4). The third study measured quality of life
using the UWQOL, HNQOL and SF-36 and found summary
scores remained stable between 2 years and long-term
follow-up (median of 78 months after the completion of
treatment) [44]. Clinically meaningful (10 point change)
Table 1
Psychosocial studies included in the systematic review
Reference
Country
Sample HPV/
p16
positive
Study design Outcomes/measures Relevant ﬁndings
[35]
USA
10 male survivors of
HPV-OSCC between 1
and 5 years treatment
completion
100%
(HPVþ)
Qualitative
semi-structured
interviews
Exploring the communication,
comprehension and
psychologic impact of a
diagnosis of HPV-related
oropharyngeal cancer
- 3/10 felt a sense of stigma or embarrassment asso-
ciated with their diagnosis
- The cancer itself occasionally or always over-
shadowed the impact of HPV
- 4/10 were concerned with potentially infecting a
partner with HPV and one expressed concerns about
re-infection
- Survivors understood and were encouraged by pos-
itive prognostic implications of an HPV diagnosis
[36]
Switzerland
98 survivors of
oropharyngeal cancer
a median of 67
months after
treatment
89%
(p16þ)
Follow-up survey
(postal)
Quality of life: EORTC QLQ-C30
and EORTC QLQ-H&N35
p16e patients had signiﬁcantly lower scores on physical
and role functions and hadmore complaints about feeling
ill and pain than p16þ patients
[37]
USA
22 patients at ﬁrst
head and neck cancer
clinic visit; 2 females,
20 males
80.9%
(HPVþ)
95.2%
(p16þ)
Longitudinal study:
baseline (preoperatively),
3 weeks, 3 months,
6 months and 12 months
Quality of life: Head and Neck
Cancer Inventory
- Speech, eating, aesthetics and social disruption
scores at 3 weeks, 3 and 6 months were signiﬁcantly
lower than at baseline
- Overall quality of life still signiﬁcantly lower than
preoperative levels at 1 year
- Signiﬁcant declines in overall quality of life at 3
months compared with 3 weeks
- No signiﬁcant impact on quality of life outcomes by
HPV status
[38]
USA
87 patients at ﬁrst
new patient referral
visit: 81 included in
analysis
63% (HPVþ)
74% (p16þ)
Prospective cohort study Quality of life: Head and Neck
Cancer Inventory
- All health-related quality of life scores declined at 3
weeks; social and overall scores continued to drop
and bottomed out at 3 months
- Social and overall scores showed at 12 months
greatest recovery signiﬁcantly from baseline
- No differences between HPVþ and HPVe patients on
any of the quality of life domains at 12 months
[39]
USA
162 medical records
e patients with
locally advanced
OSCC, known p16
status and treated by
chemoradiation or
primary surgery
followed by adjuvant
radiation therapy;
142 men, 20 women
69%
(p16þ)
Audit of
medical records
Prevalence of anxiety disorder
and major depression in
patients with HPVþ and
HPVe tumours
- No signiﬁcant differences between HPVþ and HPVe
patients for rates of major depression or anxiety
disorder
- Higher prevalence of anxiety in HPVe patients
(continued on next page)
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Table 1 (continued)
Reference
Country
Sample HPV/
p16
positive
Study design Outcomes/measures Relevant ﬁndings
[40]
USA
177 patients with
HNSCC and known
HPV/p16 status
diagnosed between
2006 and 2012
45%
(p16þ)
Longitudinal
study: baseline,
2 months, 6 months,
1 year and 1e3 years
Quality of life: UWQOL - p16þ patients had signiﬁcantly better overall quality
of life, recreation and chewing scores at baseline
- p16þ patients had better activity, recreation, overall
quality of life at 6 months
- No long-term differences in quality of life for p16e
patients treated with primary surgery or
chemoradiation
[41]
Italy
79 patients with
HNSCC; 17women, 62
men
Control group:
healthy subjects
matched for gender
and disease
proportion attending
same clinic for non-
pathological reasons
100%
(HPVþ)
Multicentre,
observational and
retrospective study
Perception of their health
conditions: EQ-5D
Measurement of utility loss
considering patient’s
perspective
- Overall quality of life in patients signiﬁcantly lower
than healthy subjects
- Utility scores were higher in men than women
[42]
USA
62 newly diagnosed
HPVþ patients
initiating
radiotherapy
98%
(p16þ)
89%
(HPVþ)
Cross-sectional survey Self-reported:
- Feelings of keeping their
HPV a secret from others
- Disclosure of HPV to
current sexual partner
- Whether HPV increased
partner’s risk
- Whether they talked to
partner about likelihood of
transmission
- How much knowledge of
HPV as a cause had
impacted their relationship
- Distress
- Self-blame
- About 30% showed marked distress
- Distress levels were moderate
- Patients reported low levels of behavioural self-
blame
- Blame and distress were signiﬁcantly correlated
- No signiﬁcant differences regarding distress and self-
blame in those self-declaring as HPVþ compared
with those who did not or were unsure
- 14% intended to keep it a secret from others and 3%
did not tell their partner e reasons included embar-
rassment, stigma, and belief it is no-one else’s
business
- 41% said they had not discussed concerns regarding
potential viral transmission to their partner
- 8% thought their HPV had entirely increased their
partners risk for developing cancer, 42% said some-
what and 29% said it did not
- 80% reported that the diagnosis had no negative
impact, 14% reported a somewhat negative impact,
6% reported a completely negative impact on
relationships
[43]
USA
228 patients
diagnosed with
primary OSCC
between 2003 and
2010
Group 1: (n ¼ 162)
HPVe and low-risk
29%
(HPVþ)
Longitudinal study:
pre-treatment, immediate
post-treatment and
1 year post-treatment
Quality of life: UWQOL - Pre-treatment quality of life scores were signiﬁcantly
higher in patients who were high-risk HPVþ
- Immediate post-treatment scores were lower in
HPVþ patients
- Post-treatment scores were similar between the two
groups
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HPV
Group 2: (n ¼ 66)
High-risk HPVþ
- Group 2 had a signiﬁcantly larger decrease in quality
of life scores from pre-treatment to immediate post-
treatment compared with group 1
- The change in quality of life scores from post-
treatment to 1 year post-treatment was similar
between the groups
- HPV status was associated with pre-treatment
quality of life and a change in quality of life from
pre-treatment to immediate post-treatment
- Patients in group 2 did not have better 1 year quality
of life compared with group 1
[44]
USA
40 head and neck
cancer survivors >2
years after treatment:
34 men, 6 women
98%
(HPVþ)
Follow-up
survey (postal)
Health-related quality of life:
HNQOL, UWQOL, SF-36
- Global HNQOL remained stable compared with 2 year
assessments for HNQOL and UWQOL
- Clinically meaningful declines in global HRQOL from
2 year assessment were reported by 8% of patients by
HNQOL and 14% of patients by UWQOL
- 8% on HNQOL and 11% on UWQOL reported mean-
ingful improvements in global HNQOL
- 84% and 75% of patients reported stable global
HRQOL compared with 2 years by HNQOL and
UWQOL
- Overall physical and mental health mean scores on
the SF-36 were comparable to US population norms
in each HRQOL domain
- Overall cohort experienced stable HNQOL scores and
statistically worse UWQOL score compared to pre-
treatment
- Clinically meaningful declines were found in global
HRQOL from pre-treatment by 8% on HNQOL and 30%
on UWQOL
HPV, human papillomavirus; HNSCC, head and neck squamous cell carcinoma; EORTC, European Organization for Research and Treatment of Cancer; UWQOL, University of
Washington Quality of Life; HNQOL, Head and Neck Quality of Life; SF-36, Short Form 36; OSCC, Oropharyngeal squamous cell carcinoma.
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R.H. Dodd et al. / Clinical Oncology 28 (2016) 421e439428declines in quality of life measured using the UWQOL was
found in 14% of patients, whereas 11% of patients reported
clinically meaningful improvements. Summary scores on
this measure between pre-treatment and long-term follow-
up were signiﬁcantly worse. Clinically meaningful (10
point change) declines in quality of life measured using the
HNQOL were found in 8% of patients, with 8% of patients
reporting clinically meaningful improvements. Summary
scores on this measure remained stable between pre-
treatment and long-term follow-up. Scores on the SF-36
for long-term physical and mental health were compara-
ble with the US population norms [44].
Cross-sectional Studies with a Comparison Group
One study compared quality of life in HPV-positive pa-
tients and HPV-negative patients using the EORTC QLQ-C30
[36]. Patients with HPV-positive tumours were found to
score signiﬁcantly better on physical and role functions of
the scale [36], but there were no signiﬁcant differences
between the groups in the emotional, social and global
health functions of the scale. In an audit of medical records,
Hess and colleagues [39] found that there was a higher
prevalence of anxiety in HPV-negative patients, but rates of
major depression or anxiety disorder did not differ signiﬁ-
cantly between the HPV-positive and HPV-negative groups.
Another study compared quality of life scores measured
using the EQ-5D between HPV-positive patients and
healthy subjects [41]. Overall quality of life was signiﬁcantly
lower in patients than in healthy subjects.
Longitudinal Studies with a Comparison Group
Four studies compared quality of life between HPV-
positive and HPV-negative patients at more than one time
point [37,38,40,43]. One study measuring quality of life
using the UWQOL [40], found that overall quality of life
scores were better at each time point for HPV-positive pa-
tients than for HPV-negative patients, with the differences
being signiﬁcant at baseline, 6 months and after 12 months.
Another study measuring quality of life using the UWQOL
[43] found that pre-treatment quality of life scores were
signiﬁcantly higher in HPV-positive patients comparedwith
HPV-negative patients, lower (but not signiﬁcantly)
immediately after treatment and similar at 1 year after
treatment. Quality of life measured using the HNCI in one
study found that HPV-positive patients had a higher quality
of life at baseline, but then a lower quality of life at 3 weeks,
3 months and 6 months compared with HPV-negative pa-
tients [37]. Another study using the HNCI found that HPV
status was not associated with quality of life outcomes at 12
months [38]. Using data from the whole sample, clinically
meaningful declines were found from baseline to 12
months in speech function, aesthetic attitude, eating func-
tion and attitude [38].
Overall, these longitudinal studies found inconsistent
results when comparing quality of life in HPV-positive pa-
tients and HPV-negative patients. Some reported HPV-
positive patients with a combination of both higher andlower quality of life scores than HPV-negative patients
depending on the time points (n ¼ 3), with differences only
signiﬁcant when the quality of life scores were higher in
HPV-positive patients. Others found no signiﬁcant differ-
ences between the groups at any time point (n ¼ 2).
Studies Assessing Knowledge of Human Papillomavirus-
related Head and Neck Cancer
Forty-one papers from 37 studies assessed knowledge
about HPV and HNC [45e85]. Over half (n ¼ 23) were
conducted in the USA [46e49,52,54,56,62,67e71,
73e78,80,82e85], with others from Germany (n ¼ 4)
[58e61], Saudi Arabia (n ¼ 3) [63e65], Canada (n ¼ 2)
[50,66], Malaysia (n¼ 2) [79,81], Jordan (n¼ 2) [45,57], Italy
(n ¼ 1) [72], Puerto Rico (n ¼ 1) [51], Romania (n ¼ 1) [55]
and Ireland (n ¼ 1) [53]. All were published between 2002
and 2015. Quantitative studies (n¼ 40) [45e51,53e85] used
survey-based data collection methods and one qualitative
study collected data using focus groups [52].
Studies assessing knowledge of HPV and HNC included
samples of dental students [48,49,55,65,81], medical stu-
dents [64,74,81,85], general undergraduate students
[66,82,83,85], oral health providers (dentists and dental
hygienists) [46,50,52,53,58e60,69,71,75,79], head and neck
surgeons [68], healthcare professionals [57,61,63,75], a
population-based sample of US men [47,76] and a
population-based sample of US adults [54,67,73,78,80].
Some speciﬁc sample populations were included, such as
American Indian community members [56], bisexual and
homosexual populations [62,72,77,84] and National Asso-
ciation for Stock Car Auto Racing (NASCAR) fans [85].
Knowledge of the association between HPV and HNC
varied across study populations and the questions asked
(Table 4). All the questions involved recognition of HPV as
either a cause or a risk factor for oral cancer, with no studies
requiring participants to recall HPV as a risk factor for oral
cancer. For example, Hertrampf and colleagues [58e61]
asked ’Which of the following factors places an individual
at high risk for oral cancers?’ with HPV listed as a response
option and Colon-Lopez and colleagues [51] asked partici-
pants to respond true or false to the statement ’HPV is asso-
ciatedwith oral cancer’. Knowledge of HPV as a risk factor for
oral cancer ranged from 26 to 91% in medical or dental pro-
fessional samples [45,46,50,53,57e61,63,68,69,71,75,79]
compared with between 1 and 44% in samples of members
of the general population
[51,54,56,60,62,67,70,72,73,76,77,80,84,47,78]. Knowledge
among students ranged from 18% in general undergraduate
students to 84% in undergraduate dental students
[48,49,55,64e66,74,81e83].
Quality Assessment
Based on the NICE quality appraisal checklists for the
quantitative studies, 27 studies were designed or con-
ducted in a way that minimised bias, nine studies were
partly designed or conducted to minimise bias and had
aspects of the study design that were unclear, and 13
Table 2
Included studies measuring knowledge of human papillomavirus (HPV) and head and neck cancer
Reference
Country
Sample Response rate Study design Outcomes/measures Relevant ﬁndings
[45]
Jordan
112 newly graduated
medical and dental SHO
level; 49% dental degree,
51% medical
Not reported Survey (in person) Knowledge of risk factors for
oral cancer (e.g. Which of the
following factors is considered
an increased factor for oral
cancer: Human papillomavirus
as a response option)
- HPV correctly identiﬁed as a risk factor by 34% - more
dental (47% versus 21%) than medical responded
correctly
[46]
USA
651 dental hygienists
fromNorth Carolina State
Board of Dental
Examiners
53% Survey (postal) Knowledge of risk factors for
oral cancer (e.g. In the United
States, which of the following
factors places an individual at
high risk for oral cancer?
Human papillomavirus as yes/
no/don’t know option)
- 47.1% knew HPV a risk factor for oral cancer
- 32% felt patients are knowledgeable about oral cancer
risk factors
[47] *
USA
609 men aged 18e59
years from population-
based panel of US
households: Men’s
Health Study
70% Survey (online) Awareness and knowledge (e.g.
Which of the following do you
think might increase the
chances of getting oral cancer?
Infection with a virus as a
response option)
Beliefs about causes of HPV-
related disease (e.g. Do you
think HPV can cause oral
cancer? Yes/no/don’t know)
- More men knew HPV can cause genital warts (41%)
than oral cancer (23%)
- 43% identiﬁed infection with a virus as a potential
cause of oral cancer (less than for anal cancer or
genital warts)
- Few believed sexual behaviours increases risk of oral
cancer (23% having sex; 26% high number of sexual
partners)
[48]
USA
248 1st, 2nd, 3rd and 4th
year dental students at
University of Maryland
Baltimore College of
Dental Surgery
59.6% Cross-sectional
survey (in person
and postal)
Knowledge of oral cancer risk
factors
- 30.8% 1st year, 89.1% 2nd year, 78.1% 3rd year, 81.8%
4th year knew HPV is a risk factor for oral cancer
[49]
USA
163 dental students,
Medical University of
South Carolina
79.1% Survey (in person) Knowledge of oral cancer risk
factors
- 79.8% correctly identiﬁed HPV as a risk factor
[50]
Canada
670 dentists, British
Columbia and Nova
Scotia
55.2% Survey (postal) Knowledge of oral cancer risk
factors
- 53.1% correctly identiﬁed HPV as a risk factor for oral
cancer
[51]
Puerto Rico
206 Men in sexually
transmitted disease clinic
Not reported Survey (in person) HPV awareness, HPV
knowledge
(e.g. HPV is associated with oral
cancer: true/false/don’t know)
- 27.4% knew HPV infection has a role in oral cancer
(continued on next page)
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Table 2 (continued)
Reference
Country
Sample Response rate Study design Outcomes/measures Relevant ﬁndings
[52]
USA
17 dentists in 2 focus
groups, 21 dental
hygienists in 2 focus
groups
Not reported Qualitative focus
groups
Assess awareness of oral health
providers regarding the HPV-
oral cancer link
Elicit attitudes and perceived
role in screening for HPV-oral
cancer lesions and discussing
HPV as a contributing factor for
oral cancer
- Participants ranged from a complete lack of knowl-
edge t nderstanding some intricacies of the HPV-
oral ca r link
- Shifts i entistry practice were seen as a result of the
HPV-o cancer link and there was a desire for
additio l guidance from professional organisation
on wa o manage screening for HPV-related oral
cancer
- Discom rt was expressed in discussing the HPV-oral
cancer k with patients, with concerns about the
approp teness of HPV-oral cancer discussions with
patien ue to conﬁdentiality and gender roles
- Respon s varied as to whether it was their role to
discuss ith patients
[53]
Ireland
254 dentists Not reported Cross-sectional
survey (online)
Knowledge of oral cancer risk
factors
- 60% kn HPV is a risk factor for oral cancer
[54]
USA
93 community members 32% Survey (telephone) Knowledge of oral cancer risk
factors
- 34% kn having HPV ’increases the risk of getting
mouth throat cancer’
[55]
Romania
192 1ste6th year dental
students; 139 female, 53
male
100% Cross-sectional
survey (in person)
Knowledge of oral cancer risk
factors
- Almos 4% identiﬁed HPV as a risk factor for oral
cancer
[56]
USA
205 American Indian
community members
recruited via two
community events; 70%
female
Not reported Survey (in person) Knowledge of the risk factors of
head and neck cancer including
HPV
(e.g. Do you think that HPV can
cause head and neck cancer?
yes/no/don’t know)
- 32% ha eard of head and neck cancer
- 23% id tiﬁed having multiple sexual partners as a
risk fa r
- 36% th ght HPV is related to head and neck cancer
[57]
Jordan
330 primary healthcare
professionals
87% Survey (face-to-
face interview)
Knowledge of oral cancer risk
factors
- 43.3% ntiﬁed Human papillomavirus as a risk
factor
[58] y
Germany
306 dentists in
Schleswig-Holstein
14% Survey (postal) Knowledge of oral cancer risk
factors (e.g. Which of the
following factors places an
individual at high risk for oral
cancers? Human
papillomavirus as yes/no/don’t
know option)
- 57.8% ntiﬁed Human papillomavirus as a risk
factor
[59]
Germany
394 dentists in
Schleswig-Holstein
17% Survey (postal) Knowledge of oral cancer risk
factors (e.g. Which of the
following factors places an
individual at high risk for oral
cancers? Human
papillomavirus as yes/no/don’t
know option)
- 61.2% ntiﬁed Human papillomavirus as a risk
factor; .4% in those participating at re-evaluation
and at ding a continuing education course on oral
cancer
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[60] y
Germany
306 dentists in
Schleswig-Holstein;
1000 members of the
public
14% Survey (postal and
telephone)
Knowledge of oral cancer risk
factors (e.g. Which of the
following factors places an
individual at high risk for oral
cancers? Human
papillomavirus as yes/no/don’t
know option)
- 57.8% of dentists and 29% of the public identiﬁed
Human papillomavirus as a risk factor
[61]
Germany
388medical practitioners
in Schleswig-Holstein
13% Survey (postal) Knowledge of oral cancer risk
factors (e.g. Which of the
following factors places an
individual at high risk for oral
cancers? Human
papillomavirus as yes/no/don’t
know option)
- Human papillomavirus recognised as risk factor by
70% otorhinolayngology, 54% GPs, 50% internal
medicine (continuing education for general medical
care), 51% internal medicine, 82% dermatologists
[62] *
USA
609 men: 312 gay and
bisexual, 296
heterosexual
70% Survey (online) Knowledge of HPV
(e.g. Do you think HPV can
cause oral cancer? Yes/no/don’t
know)
- 21% of heterosexual men and 25% of gay/bisexual
men knew HPV can cause oral cancer
[63]
Saudi Arabia
236 healthcare
professionals
Not reported Cross-sectional
survey
Knowledge of oral cancer risk
factors
- 39.1% knew Human papillomavirus is a risk factor for
oral cancer
[64]
Saudi Arabia
167 undergraduate
medical students (all
students in years 4e6)
100% Cross-sectional
survey (in person)
Knowledge of oral cancer risk
factors (e.g. Which of the
following factors places an
individual at high risk for oral
cancers? Human
papillomavirus as yes/no/don’t
know option)
- 65.7% overall identiﬁed Human papillomavirus as
high-risk factor of oral cancer
- Male 4th year 19%; 5th year 17%, 6th year 16%
- Female 4th year 5%, 5th year 4%, 6th year 4%
[65]
Saudi Arabia
479 undergraduate
dental students (all
students in years 4e6)
87.1% Cross-sectional
survey (in person)
Knowledge of oral cancer risk
factors
- 83.7% identiﬁed Human papillomavirus as placing
someone at high risk for oral cancer
- Male 4th year 10%; 5th year 15%; 6th year 15%
- Female 4th year 12%; 5th year 15%; 6th year 16%
[66]
Canada
176 males at
postsecondary
institutions in Greater
Vancouver
Not reported Survey (in person) Knowledge of HPV - 32.9% knew ’HPV infections can cause oral cancers’
and 24.2% knew ’HPV infections can cause pharyn-
geal (throat) cancers’
[67]
USA
2126 US adults from
Harris Interactive online
panel
Not reported Cross-sectional
survey (online)
Awareness
(e.g. Did you know that the
virus HPV (human
papillomavirus) that causes
cervical cancer is also
associated with throat cancer?)
Knowledge
(e.g. How knowledgeable are
you about oral, head, and neck
cancer? Likert scale not at all to
extremely knowledgeable)
- 66% considered themselves not very or not at all
knowledgeable about head and neck cancer
- Knowledge of HPV as a risk factor in 0.8%
- 12.8% were aware of this association when specif-
ically queried about the association between HPV and
throat cancer
- Respondents with a college or university degreewere
more likely to associate HPV with throat cancer
(14.8% versus 10%)
- Older age was associated with less knowledge of HPV
as a risk factor
(continued on next page)
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Table 2 (continued)
Reference
Country
Sample Response rate Study design Outcomes/measures Relevant ﬁndings
[68]
USA
297 American Head and
Neck Society head and
neck surgeons
27.5% Survey (online) Assess clinical practices
Assess attitudes
Assess knowledge regarding
HPV-related cancer of the head
and neck
- 90.9% said they discuss HPV as a risk factor with
patients
- Respondents speciﬁcally with daughters - about 85%
discussed HPV as a risk factor
- Scored very well on knowledge items of HPV - in 5
out of 7, over 92% of responses were correct
[69]
USA
619 dentists in Maryland 53.6% Survey (postal) Knowledge of oral cancer risk
factors
- 88% knew HPV is a risk factor for oral cancer
[70]
USA
303 drag racers (28.3%)
and fans (70%), vendors
(1.7%) attending annual
United Black Drag Racers
drag racing event in St
Louis
Not reported Survey (in person) Knowledge of HPV and head
and neck cancer
(e.g. Please indicate whether
you think that each of these
things may or may not increase
a person’s chance of getting
head and neck cancer: Human
papillomavirus infection;
certain types of HPV can lead to
oral cancer: True)
- 29.9% knew HPV deﬁnitely increases the risk of
developing oral, head and neck cancer
- Male 49%; Female 62.6%
[71]
USA
584 licensed dentists in
North Carolina
52% Survey (postal) Knowledge of oral cancer risk
factors
(e.g. In the United States, which
of the following factors places
an individual at high risk for
oral cancer? Human
papillomavirus listed as an
option)
- 60% aware of Human papillomavirus as a risk factor
[72]
Italy
1000 lesbian, gay and
bisexual men and
women
86.8% Cross-sectional
survey (in person)
Know that HPV can cause
oropharyngeal cancer
- 47% gay men, 44% lesbians, 31% bisexual men and
35% of bisexual women knew oral cancer is an HPV-
related disease
- The vast majority knew unprotected sex was the
main risk factor
- 60.6% had heard of HPV
[73]
USA
62 senior citizens 66% Survey (in person) Knowledge of oral cancer risk
factors
- 29.5% knew infection with HPV was a contributing
factor for oral cancer
[74]
USA
450 medical students,
South Carolina
78.8% Cross-sectional
survey (in person)
Knowledge of oral cancer risk
factors
- 61.4% overall knew HPV is associated with an
increased risk for oral cancer; 33.7% 1st year; 58.7%
2nd year; 80.8% 3rd year; 64.7% 4th year
[75]
USA
269 dentists, 19 oral
surgeons, 221 physicians
57% dentists
76% oral
surgeons
45%
physicians
Cross-sectional
survey (postal)
Knowledge of oral cancer risk
factors (e.g. Rank (high,
medium, low) the association of
known high-risk factors
(Human papillomavirus) with
oral cancer)
- Human papillomavirus ranked as high risk by 26%
dentists, 37% physicians; medium risk by 49% den-
tists and 45% physicians; low risk by 26% dentists,
37% physicians
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[76] *
USA
609 men aged 18e59
from national panel of US
households
70% Cross-sectional
survey (online)
Knowledge of HPV
(e.g. Do you think HPV can
cause oral cancer? Yes/no/don’t
know)
- 21% of those having heard of HPV responded yes to
HPV can cause oral cancer
[77] *
USA
306 men self-identiﬁed
as gay or bisexual aged
18e59 from national
panel of US households
70% Cross-sectional
survey (online)
Knowledge of HPV
(e.g. Do you think HPV can
cause oral cancer? Yes/no/don’t
know)
- 25% of those having heard of HPV responded yes to
HPV can cause oral cancer
[78]
USA
2393 general population
from rural areas
Not reported Survey (telephone) Knowledge of risk factors for
mouth and throat cancer
- 40.2% Having Human papillomavirus ’Yes-it increases
the risk of getting mouth or throat cancer’
[79]
Malaysia
362 dentists 41.7% Survey (in person) Knowledge of oral cancer risk
factors
- 67.2% knew Human papillomavirus is a risk factor for
oral cancer
[80]
USA
267 parents of sons
eligible to receive HPV
vaccination
Not reported Cross-sectional
survey (in person)
Parents’ knowledge of HPV in
oropharyngeal cancer
- 18% knew role of HPV in oropharyngeal cancer
[81]
Malaysia
147 ﬁnal year medical
and dental
undergraduates of
Universiti Sains Malaysia
73.5% Survey (in person) Aetiology of oral cancer - 59.6% of medical students and 75.6% of dental stu-
dents knew of role of HPV in aetiology of oral cancer
(not statistically signiﬁcant difference)
[82]
USA
68 male African
American college
students, St Louis
Not reported Cross-sectional
survey (online)
Knowledge of HPV - 60.2% knew HPV can cause oral cancer in men; 61.7%
knew HPV can cause oral cancer in women
[83]
USA
361 freshman students at
Texas State University
10.7% Survey (online) Knowledge:
- HPV can be contracted
through oral sex
- HPV has a strong correla-
tion with oropharyngeal
cancer
- HPV is associated with
some head and neck
cancers
- 71.5% knew HPV could be contracted through oral
sex
- 51.6% knew of an association between HPV and
oropharyngeal cancer
- 18.2% knew HPV is associated with some head and
neck cancers
[84]
USA
179 men self-identiﬁed
as gay and bisexual aged
18e29 from student
organisations and social
networking sites
Not reported Survey (online) Knowledge of HPV - 25% of those having heard of HPV responded yes to
HPV can cause oral cancer
[85]
USA
491 NASCAR fans, 158
medical students, 186
undergraduate students
Not reported Survey (in person) Awareness of relationship
between HPV and head and
neck cancer
(e.g. How much do you agree
that HPV increases the risk of
head and neck cancer?)
- Mean score: Medical students 2.84; Undergraduates
2.31; NASCAR 2.63
* These four papers used the data from one study.
y These two papers used the data from one study.
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R.H. Dodd et al. / Clinical Oncology 28 (2016) 421e439434studies were either unclear on aspects of the study re-
ported or may not have addressed all potential sources of
bias. No studies were assessed as having signiﬁcant sources
of bias across all aspects of the study design. Most studies
described the source population well, used reliable and
valid outcome measures, measured outcomes that were
relevant and used appropriate analytical methods. Of 25
studies in which it was relevant to carry out a power
calculation, only eight did so. Many of the studies had small
samples and so could not be generalised to the source
population. For the two qualitative studies, both were clear
in the purpose of the study, carried out the data collection
appropriately, were clear on the context in which the study
was carried out, conducted reliable analysis, provided
convincing ﬁndings and drew relevant conclusions. Both
studies were unclear about whether the relationship be-
tween the researcher and participants had beenTable 3
Scores from psychosocial measures in human papillomavirus (HPV)-re
Reference Measure H
[36] Quality of life - EORTC QLQ-C30 (median score
Emotional 91
Social 10
Global health 83
[37] Quality of life - HNCI (mean score; scale range
Baseline 94
3 weeks 79
3 months 48
6 months 63
12 months 88
[38] Quality of life - HNCI (mean score; scale range
12 months 75
[40] Quality of life - UWQOL (mean score across 12
Baseline 76
2 months 57
6 months 67
12 months 69
>12 months 82
[43] Quality of life - UWQOL (mean score across 12
Pre-treatment 86
Immediate post-treatment 63
Post-treatment 75
[39] Major depression 9%
Anxiety disorder 6%
[42] Distress (mean; scale range) 3.
Self-blame (mean; scale range) 2.
[41] EQ-5D (mean utility values)
Women 0.
Men 0.
[44] Quality of life - UWQOL (mean score; scale ran
Pre-treatment 10
24 months 15
Long term 16
HNQOL (mean score; scale range 0e100)
Pre-treatment 15
24 months 9.
Long term 11
EORTC, European Organization for Research and Treatment of Cancer
Washington Quality of Life; HNQOL, Head and Neck Quality of Life.
* One reference not included as used qualitative methodology [35].considered. Both studies were considered to be designed to
have minimised bias.Discussion
This review is the ﬁrst to draw together the emerging
literature on the psychosocial implications of an HPV-
related HNC diagnosis and awareness of the link be-
tween HPV and HNC. Quality of life was measured in the
HPV-related HNC patient population, with inconsistent
results found. Quality of life in those with HPV-positive
HNC was found to be higher, lower or equivalent to
those with HPV-negative HNC. In longitudinal studies,
irrespective of the instrument used, quality of life in pa-
tients was at its lowest 2e3 months after diagnosis. In
some studies, quality of life almost returned to baselinelated head and neck patients in nine* studies
PVþ HPVe Signiﬁcant difference
; scale range 0e100)
.67 83.33 NS
0 100 NS
.33 79.17 NS
0e100)
75 NS
88 NS
58 NS
83 NS
/ NS
0e100)
78 NS
domains; scale range 0e100)
50 0.008
51 NS
59 0.034
64 NS
65 0.013
domains; scale range 0e100)
79 0.015
73 NS
77 NS
10% NS
12% NS
38 (0e9) /
27 (1e4) /
7 /
8 /
ge 0e100)
/
.2 /
.5 /
.1 /
5 /
.9 /
; HNCI, Head and Neck Cancer Inventory; UWQOL, University of
Table 4
Knowledge about human papillomavirus (HPV) and oral cancer reported in 35* studies
Question % (reference) Sample population
Heard of HPV . (closed question) 70.6% [47] General population men (USA)
61% [76] General population men (USA)
79% [77] General population men (USA)
93% [84] General population men (USA)
60.6% [72] General population (Italy)
59% [56] General population (USA)
80% [66] College students (Canada)
85% [82] College students (USA)
HPV as a risk factor for oral cancer
was known by. (closed question)
53.1% [50] Dentists (Canada)
60% [71] Dentists (USA)
57.8% [58] Dentists (Germany)
26% [75] Dentists (USA)
61.2% [59] Dentists (Germany)
60% [53] Dentists (Ireland)
57.8% [60] Dentists (Germany)
88% [69] Dentists (USA)
67.2% [79] Dentists (Malaysia)
47.1% [46] Dental hygienists (USA)
79.8% [49] Dental students (USA)
66.5% [48] Dental students (USA)
54% [55] Dental students (Romania)
83.7% [65] Dental students (Saudi Arabia)
34% [45] Newly graduated medical and dental personnel (Jordan)
37% [75] Physicians (USA)
39.1% [63] Healthcare professionals (Saudi Arabia)
91% [68] Head and neck surgeons (USA)
50e82% [61] Medical practitioners (Germany)
43.3% [57] Healthcare professionals (Jordan)
61.4% [74] Medical students (USA)
65.7% [64] Medical students (Saudi Arabia)
44% [72] General population (Italy)
29% [60] General population (Germany)
32% [54] General population (USA)
40.2% [78] General population (USA)
0.8% [67] General population (USA)
29.5% [73] General population (USA)
29.9% [70] General population (USA)
18% [80] General population (USA)
Knew HPV can cause oral cancer/
head and neck cancer
23.3% [47] General population men (USA)
21% [76] General population (USA)
25% [77] General population (USA)
39% [84] General population men (USA)
21e25% [62] General population men (USA)
27.4% [51] General population men (Puerto Rico)
36% [56] General population (USA)
12.8% [67] General population (USA)
18.2% [83] College students (USA)
59.6% [81] Medical Students (Malaysia)
75.6% [81] Dental Students (Malaysia)
32.9% [66] College students (Canada)
60.2% in men [82] College students (USA)
61.7% in women [82] College students (USA)
Knew HPV is strongly associated
with oropharyngeal cancer
51.6% [83] College students (USA)
* Two references not included as the studies did not use comparable methodology [52,85].
R.H. Dodd et al. / Clinical Oncology 28 (2016) 421e439 435levels after 12 months. The UWQOL was the instrument
used in three of the 10 studies included in this review.
This scale is speciﬁc to HNC and measures 12 different
domains as single-item questions. To allow forcomparisons across studies, it would be ideal to have a
well-validated, standardised measure that could be used
in all studies. As previously reported, it is difﬁcult to make
generalised statements about quality of life that can aid in
R.H. Dodd et al. / Clinical Oncology 28 (2016) 421e439436clinical decision making, due to inconsistencies in the
design of quality of life instruments for HNC and a lack of
uniﬁed reporting standards [86].
Use of other psychosocial measures was limited, with
only one other primary research study measuring do-
mains other than quality of life. This one study found
clinically meaningful levels of distress in 30% of patients,
but relatively low levels of self-blame [42], suggesting
there may be a need for interventions that may help
alleviate distress levels. In the one qualitative study, a few
survivors of HPV-positive HNC reported feelings of stigma
and embarrassment about their diagnosis and this
affected their sexual relationships, consistent with ﬁnd-
ings from the cervical cancer literature [24] and previous
research with health professionals documenting concerns
of HPV-positive HNC patients [87]. It is therefore difﬁcult
to draw conclusions based on the limited research that
has been conducted around the psychosocial impact of
HPV-related HNC. Future work is needed to explore the
psychosocial impact of this diagnosis on the patient
group, as well as their partners, the general population
and health professionals.
The relationship between HPV and HNC is not well-
known across most populations in the studies included
here. The most knowledgeable group about HPV as a risk
factor for HNC were second year dental students, dentists
and head and neck surgeons (>85%), compared with one
study ﬁnding that less than 1% of US adults knew that HPV
is a risk factor for HNC. Awareness levels ranged across a
variety of samples of the general population, dentists, stu-
dents and speciﬁc sexually orientated groups, from 18 to
67%. Almost half the studies included dentists, dental hy-
gienists or dental students, suggesting that the role dentists
have to play in HPV and HNC is being increasingly recog-
nised and educating them about HPV as a risk factor is
important. All the questions were recognition questions
rather than recall and so may not represent the true
knowledge of participants as previous studies have found
awareness to be higher in participants when responding to
recognition questions when compared with recall [88,89].
One study assessing knowledge in medical practitioners in
Ireland found that when asked to list the risk factors they
would associate with oral cancer, HPV was not listed [90].
There was also no standardised question assessing knowl-
edge of the link between HPV and HNC, some asking it as a
risk factor, whereas others were more speciﬁc (e.g. HPV is
associated with some head and neck cancers). None of these
studies were conducted in the UK, so no conclusions can be
drawn about the level of knowledge in the UK. These studies
were mainly from the USA, indicating a wide range of
knowledge across different population subgroups, but that
generally, there is a need for greater awareness.
Strengths and Limitations
Adhering to PRISMA guidelines ensured this review was
carried out systematically. By including quantitative and
qualitative studies in the review, we avoided exclusion of
any eligible and relevant studies. As a number of differentinstruments were used to measure quality of life and at
different points in the patient care continuum, it was difﬁ-
cult to compare across studies.Conclusions
A limited number of studies have measured the psycho-
social impact of a diagnosis of HPV-positive HNC and those
few that have, have only measured this in patient pop-
ulations. Future work is needed with the partners of HPV-
positive HNC patients and health professionals caring for
these patients. The limited knowledge of the association
between HPV and HNC among the public also indicates the
need for research to explore the information that these
populations are receiving. The development of collaborations
between behavioural scientists and clinicians in thisﬁeldwill
help to ensure that awareness of the role of HPV in HNC is
raised, and that the adverse psychological consequences
associated with diagnosis are understood and minimised.Acknowledgements
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